A Giant Step Forward, INNOVAX’s Hecolin® Is Expected to Enter the Pakistani Market Early 2018!

Drug Regulatory Authority of Pakistan announced the approval of Hepatitis E vaccine, Hecolin? as per import policy for finished drugs and valid legalized COPP on July 15 this year. Dr. Huma Qureshi, the Executive Director of Pakistan Research Council strongly recommends the use of HEV vaccine in Pakistan: “Making use of the available data from Pakistan and the mortality due to Hepatitis E in pregnancy, it is evident that there is a need to make HEV vaccine accessible and affordable for Pakistani women in particular and population in general.” as commented by her.

To complete the final stage of registration, the application has been submitted for site inspection and we are looking forward to a launch of Hecolin? in the first overseas market soon.

2020 - Wantai BioPharm. All Rights Reserved. Designed & Developed by SweeneyVesty Studio